Beaver Sandra, CFO of Evolus, Inc. ($EOLS), sold shares on the open market twice in the last year, totaling about $184 thousand. Her most recent sale occurred on May 13, 2025. These sales rank 8,593rd among nearly 12,000 individual insiders, where the average is $8.6 million across about 6 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2025 | TANDEM DIABETES CARE INC | $TNDM | Beaver Sandra | Director | A | Restricted Stock Unit | 20242 | $0.00 | 20,242.0000 | 67,802,359 | 9999.99% | 0.03% |
| May 13, 2025 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 6494 | $10.02 | 167,089.0000 | 63,586,753 | 3.74% | 0.01% |
| March 18, 2025 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 8996 | $13.26 | 173,583.0000 | 63,586,753 | 4.93% | 0.01% |
| March 7, 2025 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Performance Restricted Stock Units | 35663 | $0.00 | 35,663.0000 | 63,586,753 | 9999.99% | 0.06% |
| March 7, 2025 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 50813 | $0.00 | 50,813.0000 | 63,586,753 | 9999.99% | 0.08% |
| March 7, 2025 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Common Stock | 35663 | $0.00 | 182,579.0000 | 63,586,753 | 24.27% | 0.06% |
| Dec. 23, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 1586 | $10.85 | 146,916.0000 | 0 | 1.07% | 0.00% |
| Sept. 6, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 3276 | $14.98 | 148,502.0000 | 0 | 2.16% | 0.00% |
| May 10, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 2423 | $12.72 | 151,778.0000 | 0 | 1.57% | 0.00% |
| March 19, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 5672 | $13.92 | 154,201.0000 | 0 | 3.55% | 0.00% |
| Feb. 21, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Common Stock | 13115 | $0.00 | 161,694.0000 | 0 | 8.83% | 0.00% |
| Feb. 22, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | S | Common Stock | 1821 | $13.08 | 159,873.0000 | 0 | 1.13% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Common Stock | 35211 | $0.00 | 148,579.0000 | 0 | 31.06% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Performance Restricted Stock Units | 17606 | $0.00 | 17,606.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | Beaver Sandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 47337 | $0.00 | 47,337.0000 | 0 | 9999.99% | 0.00% |